3,014 results
Search Results
2. PLGA 50:50 nanoparticles of paclitaxel: Development, in vitro anti-tumor activity in BT-549 cells and in vivo evaluation
3. HPLC Determination of Gemifloxacin in Different Tissues of Rats Under Normobaric and Hyperbaric Exposure
4. Klinisch relevante pharmakokinetische Arzneimittelinteraktionen in der Intensivmedizin: Eine Übersicht
5. Klinisch relevante pharmakokinetische Arzneimittelinteraktionen in der Intensivmedizin: Eine Übersicht
6. Pharmacokinetics of levodopa
7. Bioactivity and pharmacokinetics of two human serum albumin–thymosin α1-fusion proteins, rHSA-Tα1 and rHSA-L-Tα1, expressed in recombinant Pichia pastoris
8. Predicting drug pharmacokinetics and effect in vascularized tumors using computer simulation
9. Pharmacokinetic studies of flumecinol in man and dog
10. Pharmacokinetics — Uses and abuses
11. Pharmacokinetic study with N-Ile1-Thr2-63-desulfato-r-hirudin in rabbits by means of bioassay
12. Ultraschallkontrastmittel: Substanzklassen, Pharmakokinetik, klinische Anwendungen, Sicherheitsaspekte
13. Rifampicin in plasma and pleural fluid after single oral doses
14. Regulatory aspects of pharmacogenetics and pharmacogenomics
15. Influence of the cytochrome P4502D6*4 allele on the pharmacokinetics of controlled-release metoprolol
16. Parametric imaging of patient pharmacokinetics
17. Individualization of theophylline infusion rate on the basis of a nonlinear compartmental pharmacokinetic model
18. Pharmacoeconomics: where is the link with pharmacokinetics and biopharmaceutics?
19. Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry
20. Use of etoposide in patients with organ dysfunction: pharmacokinetic and pharmacodynamic considerations
21. Pharmacokinetics of endogenous substances: Some problems and some solutions
22. Stereoselective pharmacokinetics of oral felodipine and nitrendipine in healthy subjects: correlation with nifedipine pharmacokinetics
23. Pharmacokinetic and pharmacodynamic data and models in clinical trials
24. A physiologically based mathematical model for the human inhalation pharmacokinetics of 1,1,2-trichloro-1,2,2-trifluoroethane
25. The normalization of total clearances for intravenous injection drugs
26. Letters to the editors Nonlinear kinetics of nortriptyline in every day practice*
27. Single dose and steady-state pharmacokinetics of 4 mg and 8 mg oral salbutamol controlled-release in patients with bronchial asthma
28. Evaluation of paraquat concentrations in paraquat poisoning
29. Pharmacokinetics of mestranol in man in relation to its oestrogenic activity
30. Pharmacodynamics and pharmacokinetics of furosemide combinations with potassium-retaining and thiazide-like diuretics: Clearance and micropuncture studies
31. Comparative pharmacokinetic analysis of amoxycillin using open two and three-compartment models
32. Tolerability and pharmacokinetics of L-648,051. A leukotriene D4-receptor antagonist, in healthy volunteers
33. Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam
34. Sulfadimethoxine — bucolome interaction in rabbits : role of N4-acetylsulfadimethoxine, a major metabolite of sulfadimethoxine
35. Pharmacokinetics and quantitative characterization of cefotiam excretion after intravenous administration to patients after cholecystectomy
36. Pharmacokinetics of spironolactone in man
37. Disposition of dibekacin in patients undergoing haemodialysis
38. Interindividual differences in chlorthalidone concentration in plasma and red cells of man after single and multiple doses
39. Pharmacokinetics of ramipril in hypertensive patients with renal insufficiency
40. Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: 1. Dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection
41. Effect of enterohepatic circulation on the pharmacokinetics of spironolactone in man
42. Evaluation of a micromethod for determination of antibiotic concentrations in plasma
43. Biochemistry and pharmacology of the crotoxin complex: II. Possible interrelationships between toxicity and organ distribution of phospholipase A, crotapotin and their combination
44. Prenatal exposure to escitalopram and/or stress in rats: A prenatal stress model of maternal depression and its treatment
45. Effect of ABCB1 polymorphisms and atorvastatin on sitagliptin pharmacokinetics in healthy volunteers
46. Assessment of the absorption, metabolism and excretion of [14C]pasireotide in healthy volunteers using accelerator mass spectrometry
47. Dopamine D2/3 occupancy of ziprasidone across a day: a within-subject PET study
48. The effects of liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases
49. Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer
50. Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.